Two Onc Docs cover image

Gastrointestinal Stromal Tumor (GIST) 2025 UPDATE

Two Onc Docs

00:00

Duration of adjuvant imatinib: 3 to 6 years

Sam reviews trials favoring three years and emerging data suggesting benefit with longer (5–6 years).

Play episode from 13:49
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app